ArticleJournal of microscopy2025
Ptychographic analysis of human bone marrow-derived mesenchymal stem cell morphology: The impact of cell senescence.
Article in Journal of microscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Glucose transporter 1 deficiency impairs glucose homeostasis, cell proliferation, and morphology in human embryonic kidney cells 293.Cell and tissue research · 2026Article
- Cytotoxic and Cytostatic Effects of Nanoformulated Fenretinide on MG63 Osteosarcoma Cells.Pharmaceutics · 2026Article
- Ptychographic analysis of human bone marrow-derived mesenchymal stem cell morphology: The impact of cell senescence.Journal of microscopy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mesenchymal stem cells (MSC) undergo replicative senescence, a state of irreversible cell cycle arrest that limits their utility in regenerative medicine applications. To identify novel markers of senescence useful to enhance the quality of MSC-based therapies, we compared young and senescent human bone marrow-derived mesenchymal stem cells (hMSCs) using a non-invasive, label-free approach based on quantitative phase imaging (QPI) with the Livecyte microscope. Senescent hMSCs demonstrated substantial morphological alterations, including a threefold increase in cell area, elevated dry mass, reduced thickness, and decreased sphericity compared to their younger counterparts. Additionally, motility metrics such as instantaneous velocity and displacement were significantly reduced in senescent cells, underscoring functional impairments that could hinder their therapeutic potential in regenerative medicine. The application of QPI offers a promising tool for monitoring cellular health, identifying, and potentially eliminating, senescent cells to improve the quality and effectiveness of MSC-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.